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Hepatitis E virus (HEV) is an important but extremely understudied human pathogen. Genotypes 1
and 2 are restricted to humans, whereas genotypes 3 and 4 are zoonotic, infecting both humans
and pigs. This report describes, for the first time, the successful rescue of infectious HEV in vitro
and in vivo from cloned cDNA of a genotype 4 human HEV (strain TW6196E). The complete
genomic sequence of the TW6196E virus was determined and a full-length cDNA clone (pHEV-
4TW) was assembled. Capped RNA transcripts from the pHEV-4TW clone were replication
competent in Huh7 cells and infectious in HepG2/C3A cells. Pigs inoculated intrahepatically with
capped RNA transcripts from pHEV-4TW developed an active infection, as evidenced by faecal
virus shedding and seroconversion, indicating the successful rescue of infectious genotype 4
HEV and cross-species infection of pigs by a genotype 4 human HEV. To demonstrate the utility
of the genotype 4 HEV infectious clone and to evaluate the potential viral determinant(s) for
species tropism, four intergenotypic chimeric clones were constructed by swapping various
genomic regions between genotypes 1 and 4, and genotypes 1 and 3. All four chimeric clones
were replication competent in Huh7 cells, but only the two chimeras with sequences swapped
between genotypes 1 and 4 human HEVs produced viruses capable of infecting HepG2/C3A
cells. None of the four chimeras was able to establish a robust infection in pigs. The availability of
a genotype 4 HEV infectious clone affords an opportunity to delineate the molecular mechanisms
of HEV cross-species infection in the future.
INTRODUCTION
Hepatitis E virus (HEV) is endemic in many developing
countries and is also responsible for sporadic cases of hepa-
titis E in some industrialized countries (Arankalle et al.,
1994; Emerson & Purcell, 2003; Meng, 2010). HEV is
classified in the genus Hepevirus of the family Hepeviridae
(Meng et al., 2011a). The genome is a single-stranded,
positive-sense RNA molecule of ~7.2 kb (Meng, 2010;
Okamoto, 2007) and consists of a short 59NCR, three ORFs
and a short 39NCR followed by a poly(A) tract (Chandra
et al., 2008; Emerson et al., 2004a; Okamoto, 2007). A cap
structure identified at the 59 end of the HEV genome is
essential for infectivity (Emerson et al., 2001; Zhang et al.,
2001). ORF1 encodes a large non-structural protein with
several putative functional domains (Ahmad et al., 2011).
The activities of the methyl/guanylyltransferase, helicase
and RNA-dependent RNA polymerase (RdRp) domains
have been demonstrated experimentally (Karpe & Lole,
2010a, b; Magden et al., 2001; Rehman et al., 2008). A
proline-rich hypervariable region (HVR) within ORF1 is
dispensable for HEV replication in vitro but critical for
infectivity in vivo (Pudupakam et al., 2009, 2011). The
major intergenotypic sequence variations among HEV
strains occur in the HVR, which differs by as much as 71%
in amino acid sequence among HEV isolates in different
3These authors contributed equally to this work.
The GenBank/EMBL/DDBJ accession number for the full-length genomic
sequence of genotype 4 human HEV strain TW6196E determined in this
study is HQ634346.
A supplementary table is available with the online version of this paper.
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genotypes (Pudupakam et al., 2009, 2011). ORF2 encodes
the capsid protein responsible for virion assembly, immu-
nogenicity and host-cell receptor binding (He et al., 2008; Li
et al., 1997, 2000; Meng et al., 2001; Riddell et al., 2000). A
junction region (JR) between ORF1 and ORF2 contains a
highly conserved stem–loop structure important for HEV
replication (Cao et al., 2010; Huang et al., 2007). ORF3
encodes a small multifunctional protein (Chandra et al.,
2008; Emerson et al., 2010b; Yamada et al., 2009). Whilst
ORF3 is dispensable for virus replication in vitro (Emerson
et al., 2006), it is required for infectivity in monkeys and pigs
(Graff et al., 2005). The 39NCR containing the poly(A) tract
binds to the RdRp to direct the synthesis of complementary-
strand viral RNA (Agrawal et al., 2001).
So far, at least four distinct genotypes of mammalian HEV
have been recognized (Emerson et al., 2004a). Genotypes 1
and 2 are restricted to humans, whilst genotypes 3 and 4
are zoonotic (Meng, 2011; Pavio et al., 2010) and have been
isolated from several animal species such as pig, deer, wild
boar, rat, mongoose and rabbit (Cossaboom et al., 2011;
Meng et al., 1997; Nakamura et al., 2006; Sato et al., 2011;
Tei et al., 2003). Two putative new genotypes of mam-
malian HEV have been identified recently in rats from
Germany and the USA (Johne et al., 2010; Purcell et al.,
2011) and in wild boars from Japan (Sato et al., 2011).
Non-human primates were infected experimentally with
genotype 3 and 4 swine HEV (Arankalle et al., 2006; Meng
et al., 1998b) and, conversely, pigs were experimentally
infected with genotype 3 (Halbur et al., 2001) and 4 (Feagins
et al., 2008) strains of human HEV. However, an attempt to
infect pigs experimentally with genotype 1 and 2 strains of
human HEV failed (Meng et al., 1998a). HEV infection in
pigs is subclinical, although microscopic hepatitis lesions do
develop in infected pigs (Halbur et al., 2001; Meng et al.,
1997). HEV infection in humans is mostly asymptomatic or
mild, with symptoms such as jaundice, abdominal pain,
nausea and vomiting, although significant risk exists in
pregnant woman (Navaneethan et al., 2008) and in patients
with chronic liver diseases (Hamid et al., 2002; Ramachandran
et al., 2004).
Molecular and biological studies of HEV have been limited
due to the inability to propagate the virus efficiently in
vitro, despite the recent successes in adapting HEV to grow
in cell-culture systems (Shukla et al., 2011, 2012; Tanaka
et al., 2009). So far, reverse genetics systems are available
only for genotype 1 human HEV, genotype 3 human and
swine HEV, and avian HEV. Unfortunately, an infectious
cDNA clone for genotype 4 human or swine HEV has not
been reported to date, even though their full-length
sequences have been determined. Thus, the availability of
an infectious clone of genotype 4 HEV will be critical for
studying the mechanism of HEV cross-species infection in
the future.
In this study, we report for the first time the successful
construction and in vitro and in vivo characterization of an
infectious cDNA clone of a genotype 4 human HEV (strain
TW6196E). Additionally, we demonstrated the utility of
this new genotype 4 HEV infectious clone for studying the
potential viral determinants of cross-species infection by
using intergenotypic chimeric viruses.
RESULTS
Genomic organization of genotype 4 human HEV
TW6196E
The TW6196E genome comprised 7256 nt, excluding the 39
poly(A) tail, with 26 nt in the 59NCR and 88 nt in the
39NCR. Three major ORFs were identified: ORF1 was
5121 nt (nt 27–5147) and encoded a product of 1706 aa;
ORF2 (nt 5186–7168) was 1983 nt and encoded 660 aa; and
ORF3, starting 32 bases downstream of ORF1, comprised
339 nt (nt 5178–5516) and encoded a small protein of
112 aa. Sequence analysis revealed that genotype 4 HEV
TW6196E shared ~74% nucleotide sequence identity with
genotype 1 HEV strains, 73% with the genotype 2 Mexican
strain, 75% with genotype 3 strains and 94% with genotype
4 strains.
Assembly of a full-length cDNA clone of genotype
4 human HEV TW6196E and demonstration of its
replication competence in vitro
Three overlapping fragments covering the entire TW6196E
viral genome were assembled by ligation at appropriate
restriction enzyme sites (Fig. 1) and cloned into vector
pGEM-7zf(2) to produce a full-length cDNA clone of
HEV strain TW6196E, designated pHEV-4TW. The pHEV-
4TW clone was positioned downstream of a T7 promoter
and a unique SpeI restriction site, allowing linearization of
the cDNA immediately downstream of the viral poly(A)
sequence. Capped RNA transcripts from the pHEV-4TW
clone were transfected into Huh7 cells to determine its
replication competence in vitro. The Huh7 hepatocellular
carcinoma cell line was used for these experiments, as it has
been shown previously that transfected HEV genomic RNA
replicates efficiently in Huh7 cells (Emerson et al., 2004b).
RNA transcripts from the genotype 1 human HEV
infectious clone pSK-HEV-2 were included as a positive
control. As expected, ORF2 viral antigens were detected by
immunofluorescent assay (IFA) in Huh7 cells transfected
with the genotype 1 pSK-HEV-2 clone (Fig. 2a). Positive
IFA signals were also detected in Huh7 cells transfected
with capped RNAs from the pHEV-4TW clone, indicating
the replication competence of this genotype 4 clone in
cultured human liver cells (Fig. 2a). No detectable IFA
signal was found in mock-transfected cells.
Intergenotypic chimeric HEVs are replication
competent in vitro
Capped RNA transcripts from the full-length cDNA clones
of each of four HEV chimeras (pSKHEV2-4h, pSKHEV2-3p,
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pHEV4TW-1h and pSHEV3-1h; see Methods and Fig. 5)
were transfected into Huh7 cells to determine their repli-
cation competence. The in vitro viability of the chimeras
pSKHEV2-4h and pSKHEV2-3p has been demonstrated
previously (Feagins et al., 2011) and was confirmed in this
study (Fig. 2b; Table 1). ORF2-specific viral antigen was
detected in the cytoplasm of Huh7 cells transfected with
the genotype 3 HEV clone pSHEV-3, as well as in those
transfected with the HEV chimeric clones pHEV4TW-1h
and pSHEV3-1h (Fig. 2b; Table 1). No detectable IFA signal
was found in mock-transfected cells. It is known that the
ORF2 protein is synthesized from subgenomic RNA; thus,
detection of ORF2 protein in Huh7 cells can be used as a
surrogate marker for replication of the chimeric viruses. The
results indicated that the ORF2 gene, along with the JR,
ORF3 and 39NCR, could be functionally exchanged between
0 kb 1 kb 2 kb 3 kb 4 kb 5 kb 6 kb
An
BamHI EcoRI
XbaI
III
II
I
T7Gn
A18
ClaI/SpeI
JR
3′NCR5′NCR
ORF2
ORF3ORF1
Met Y P HVR X Hel RdRp AnCap
pHEV-4TW 
Fig. 1. Construction of a full-length cDNA clone of genotype 4 human HEV strain TW6196E. The HEV genome consists of
three ORFs (ORF1, ORF2 and ORF3), a JR, a short 59NCR and 39NCR, a 59 cap structure and a 39 poly(A) tract. The putative
ORF1 functional domains are indicated: Met, methyltransferase; Y, Y domain; P, papain-like cysteine protease; HVR,
hypervariable region; X, X domain; Hel, helicase; RdRp, RNA-dependent RNA polymerase. BamHI and EcoRI are unique
restriction sites naturally present in the genomic sequence of strain TW6196E and were used to facilitate construction of the
full-length cDNA clone. An XbaI site and a T7 promoter sequence were introduced at the 59 end of fragment I. Eighteen As and
the restriction sites SpeI and ClaI were introduced at the 39 end of fragment III. Fragments I, II and III were ligated into the
pGEM-7zf(”) vector to generate the full-length cDNA clone, designated pHEV-4TW.
(a)
2-VEH-KSp
(b)
pSHEV-3 pSKHEV2-4h
pHEV-4TW Mock
MockpHEV4TW-1h
pSKHEV2-3p
pSHEV3-1h
Fig. 2. Replication competence of the geno-
type 4 human HEV pHEV-4TW clone and
intergenotypic chimeric viruses in Huh7 cells.
(a) IFA staining for HEV ORF2 antigen in Huh7
cells transfected with capped RNA transcripts
from the cDNA clones of genotype 1 human
HEV (pSK-HEV-2) and genotype 4 human
HEV (pHEV-4TW). (b) IFA staining for HEV
ORF2 antigen in Huh7 cells transfected with
capped RNA transcripts from the cDNA clones
of genotype 3 swine HEV (pSHEV-3) and
each of the four intergenotypic chimeric viruses
(pSKHEV2-4h, pSKHEV2-3p, pHEV4TW-1h
and pSHEV3-1h). Mock, Mock-infected cells.
Genotype 4 HEV infectious clone and chimeras
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genotypes 1 and 4, and between genotypes 1 and 3, with
respect to their ability to replicate in vitro.
Recovery of infectious viruses in vitro from Huh7
cells transfected with genotype 4 pHEV-4TW and
intergenotypic chimeric clones pSKHEV2-4h and
pHEV4TW-1h
To determine whether the genotype 4 HEV pHEV-4TW
clone was capable of producing infectious virus in vitro,
HepG2/C3A cells were inoculated with lysates of Huh7 cells
transfected with the capped RNA of clone pHEV-4TW. The
HepG2/C3A hepatocellular carcinoma cell line was used
for the in vitro infectivity assay, as previous studies have
demonstrated that HepG2/C3A cells are infected more
efficiently with HEV than Huh7 cells (Emerson et al.,
2010b). Cytoplasmic fluorescence signals were detected by
IFA in HepG2/C3A cells infected with lysates of Huh7 cells
transfected with genotype 4 clone pHEV-4TW as well as
with the wild-type genotype 1 clone pSK-HEV-2 (Fig. 3a;
Table 1), indicating the presence of infectious virus
particles derived from the genotype 4 HEV clone in
Huh7 cell lysates. HepG2/C3A cells inoculated with lysates
from mock-transfected cells did not show any evidence of
infection.
To investigate further the effects of the JR, ORF3, ORF2
and 39NCR exchange between HEV genotypes on viral par-
ticle production, we examined whether infectious chimeric
virus particles could be recovered from the transfected
Table 1. Replication competence in Huh7 cells and infectivity in HepG2/3A cells and in pigs of wild-type swine HEV genotype 3 and
human HEV genotype 4, as well as intergenotypic chimeric HEV clones
Inoculum Replication competence in
Huh7 cells
Infectivity in
HepG2/3A cells
Infectivity in pigs
pSK-HEV-2 (genotype 1 human HEV) + + 2*
pSHEV-3 (genotype 3 swine HEV) + + +
pHEV-4TW (genotype 4 human HEV) + + +
Chimera pSKHEV2-4h + + 2
Chimera pSKHEV2-3p + 2 2
Chimera pHEV4TW-1h + + 2
Chimera pSHEV3-1h + 2 2D
*The lack of infectivity in pigs of the genotype 1 human HEV was tested in a previous study (Meng et al., 1998a).
DOne pig inoculated with chimera pSHEV3-1h repeatedly tested positive for HEV RNA in bile collected during necropsy at 8 weeks p.i.
(a)
(b)
2-VEH-KSp
pSHEV-3 pSKHEV2-4h
pHEV-4TW Mock
MockpHEV4TW-1h
pSKHEV2-3p
pSHEV3-1h
Fig. 3. Infectivity of the genotype 4 HEV
pHEV-4TW clone and intergenotypic chimeric
viruses in HepG2/C3A cells. (a) IFA staining
for HEV ORF2 antigen in HepG2/C3A cells
infected with lysates of Huh7 cells transfected
with capped RNA transcripts from the cDNA
clones of genotype 1 human HEV (pSK-HEV-
2) and genotype 4 human HEV (pHEV-4TW).
(b) IFA staining for HEV ORF2 antigen of
HepG2/C3A cells infected with lysates of
Huh7 cells transfected with capped RNA
transcripts from the cDNA clone of the
genotype 3 swine HEV (pSHEV-3) and each
of the four intergenotypic chimeric viruses
(pSKHEV2-4h, pSKHEV2-3p, pHEV4TW-1h
and pSHEV3-1h).
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Huh7 cells. Cells that were IFA positive for ORF2 protein
were observed in HepG2/C3A cells inoculated with lysates
of Huh7 cells transfected with chimeras pSKHEV2-4h and
pHEV4TW-1h, as well as with the wild-type genotype 3
HEV pSHEV-3, indicating that assembly of chimeric
infectious virus particles had occurred (Fig. 3b; Table 1).
However, no detectable IFA signal was found in HepG2/
C3A cells inoculated with lysates of Huh7 cells transfected
with the RNA transcripts from chimeras pSKHEV2-3p and
pSHEV3-1h (Fig. 3b; Table 1) or with lysates from mock-
transfected cells.
Capped RNA transcripts from the genotype 4 HEV
pHEV-4TW clone are infectious when injected
intrahepatically into the livers of specific-
pathogen-free (SPF) pigs
The in vivo infectivity of the genotype 4 HEV pHEV-4TW
clone was tested by direct intrahepatic inoculation of
capped RNA transcripts into the liver of SPF pigs. All three
pigs in the wild-type genotype 3 HEV pSHEV-3 (positive
control) group shed virus in their faeces starting at 1 week
post-inoculation (p.i.). In addition, transient viraemia and
seroconversion to HEV antibodies starting at 4 weeks p.i.
were observed in pig #173 and #177 (Table 2; Fig. 4a). HEV
RNA was also detected in a bile sample collected from a
single pig (#196) during necropsy at 8 weeks p.i. (Table 2).
Similarly to the genotype 3 swine HEV pSHEV-3 group,
faecal virus shedding was detected in all three pigs ino-
culated with the genotype 4 human HEV pHEV-4TW clone
starting as early as 1 week p.i. and lasting for 2–4 weeks
(Table 2). Seroconversion to HEV antibodies was detected at
5–7 weeks p.i. in two of the three pigs (#179 and #200)
inoculated with the genotype 4 HEV clone pHEV-4TW (Fig.
4b), indicating the successful rescue of infectious genotype 4
HEV in pigs from the cloned cDNA. Sequence analysis of the
PCR-positive products confirmed that the viruses recovered
from the infected pigs originated from their respective
inocula (data not shown).
ORF2 and ORF3 genes from genotype 3 and 4 HEV
fail to enable chimeric viruses based on the
backbone of genotype 1 HEV to infect pigs
Capped RNA transcripts from the four intergenotypic
chimeric viruses were inoculated intrahepatically into the
livers of pigs to assess their infectivity in vivo. The cell
lysates of Huh7 cells transfected with chimeric clones
pSKHEV2-3p and pSKHEV2-4h failed to infect pigs in a
previous study (Feagins et al., 2011). Due to the inefficient
propagation of HEV in Huh7 cells, the amount of infec-
tious virus that can be recovered from transfected Huh7
cells is very low and thus may not be sufficient to elicit an
infection in pigs. Therefore, in this study, in addition to
testing the infectivity of the two new chimeric viruses
pHEV4TW-1h and pSHEV3-1h, we also re-evaluated the
ability of chimeras pSKHEV2-4h and pSKHEV2-3p to
infect pigs by direct intrahepatic inoculation of pigs with
large quantities of capped RNA transcripts. All pigs ino-
culated with each of the four chimeras remained sero-
negative throughout the study (data not shown) and none
shed virus in faeces or developed viraemia (data not
shown), with the exception of a single pig inoculated with
the chimera pSHEV3-1h, which repeatedly tested positive
Table 2. Detection of HEV RNA in faecal/serum samples using ORF2-specific primers in pigs inoculated intrahepatically with capped
RNA transcripts from genotype 3 swine HEV pSHEV-3, genotype 4 HEV pHEV-4TW and intergenotypic chimeras pHEV4TW-1h
and pSHEV3-1h
Pigs in the groups inoculated with the intergenotypic chimeric clones pSKHEV2-4h, pSKHEV2-3p and pHEV4TW-1h remained negative
throughout the study and are not included in the table. Necropsy was at 56 days p.i. IC, Intestinal contents.
Inoculum Pig # HEV RNA detection* HEV RNA at necropsy
0 7 14 21 28 35 42 49 56 Liver Bile IC
pSHEV-3 173 2/2 2/2 +/2 +/2 2/+ 2/2 2/2 2/2 2/2 2 2 2
177 2/2 2/2 2/2 2/2 +/+ 2/2 2/2 2/2 2/2 2 2 2
196 2/2 +/2 2/2 2/2 2/2 2/2 2/2 +/2 2/2 2 + 2
pHEV-4TW 179 2/2 2/2 2/2 2/2 2/2 +/2 +/2 2/2 +/2 2 2 2
197 2/2 +/2 +/2 2/2 2/2 2/2 2/2 2/2 2/2 2 2 2
200 2/2 +/2 +/2 +/2 +/2 2/2 2/2 2/2 2/2 2 2 2
pSHEV3-1h 157 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2 + 2
162 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2 2 2
164 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2 2 2
PBS 156 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2 2 2
178 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2 2 2
193 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2 2 2
*Positive (+) or negative (–) HEV RNA detection in faecal/serum samples at the indicated days p.i.
Genotype 4 HEV infectious clone and chimeras
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for HEV RNA in bile collected during necropsy at 8 weeks
p.i. (Table 2). The positive PCR result from bile of the
single pig was verified with a confirmatory nested RT-PCR
using a different set of primers specific for the ORF1 gene
(Table S1, available in JGV Online). The PCR product was
also confirmed by sequencing. As expected, the three pigs
in the negative-control group (#156, #178 and #193)
remained negative for HEV antibodies and viral RNA
throughout the study (Fig. 1c).
DISCUSSION
The availability of infectious cDNA clones of genotypes 1
and 3 and avian HEV has provided ample opportunities to
study the molecular mechanism of HEV replication and
pathogenesis (Feagins et al., 2011; Pudupakam et al., 2011;
Shukla et al., 2011). Unfortunately, an infectious cDNA
clone of genotype 4 human or swine HEV has not been
available. Therefore, the main objective of this study was to
develop an infectious cDNA clone of a genotype 4 human
HEV. We also aimed to utilize the newly developed
genotype 4 HEV infectious clone to explore potential viral
genetic determinants for species tropism using the inter-
genotypic chimeric virus strategy.
We demonstrated that capped RNA transcripts from the
genotype 4 human HEV pHEV-4TW cDNA clone were
replication competent in Huh7 cells and produced infec-
tious virus particles capable of infecting HepG2/C3A cells.
Importantly, we showed that SPF pigs inoculated intrahe-
patically with capped RNA transcripts from the genotype 4
HEV pHEV-4TW clone became infected, as evidenced by
faecal virus shedding and seroconversion to HEV antibod-
ies. Therefore, the results from this study indicated that
the genotype 4 human HEV pHEV-4TW cDNA clone is
infectious in vitro and in vivo, and is able to cross species
barriers and infect pigs. The patterns of faecal virus shedding
0
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0.8
1.0
1.2
0          7         14        21        28        35        42       49         56
179
197
200
Time p.i. (days)
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(a) (b)
(c)
A
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0          7         14        21        28        35        42       49         56
0          7         14        21        28        35        42       49         56
0
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0
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1.2
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Fig. 4. Seroconversion to anti-HEV IgG in pigs inoculated with capped RNA transcripts from the genotype 3 swine HEV
pSHEV-3 clone and genotype 4 human HEV pHEV-4TW clone. An ELISA (A405) was used to detect IgG anti-HEV antibodies
in pigs #173, #177 and #196 inoculated intrahepatically with capped RNA transcripts from the wild-type pSHEV-3 clone
(positive control) (a), pigs #179, #197 and #200 inoculated intrahepatically with capped RNA transcripts from the genotype 4
human HEV pHEV-4TW clone (b), and pigs #156, #178 and #193 inoculated intrahepatically with PBS (negative control) (c).
The ELISA cut-off value is shown as a dotted line.
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and seroconversion in pigs inoculated intrahepatically with
RNA transcripts from the pHEV-4TW clone were similar to
those inoculated with the genotype 3 swine HEV clone
pSHEV-3 and with the live infectious virus stock of the
genotype 4 human HEV (Feagins et al., 2008).
To demonstrate further the utility of the genotype 4 HEV
infectious clone and to gain a better understanding of the
molecular mechanism of HEV interspecies transmission,
we subsequently constructed four intergenotypic chimeric
viruses by swapping the ORF2 gene along with its JR, ORF3
and 39NCR between genotype 1 and genotype 4, and
between genotype 1 and genotype 3, HEV infectious clones.
We showed that all four intergenotypic chimeric viruses
(pSKHEV2-4h, pSKHEV2-3p, pHEV4TW-1h and pSHEV3-
1h) were replication competent in Huh7 cells, indicating
that the intergenotypic gene swaps did not disrupt virus
replication competence. However, only chimeras pSKHEV2-
4h and pHEV4TW-1h along with the wild-type genotype 3
and 4 clones produced infectious viruses capable of infecting
HepG2/C3A cells. The ability of chimeras pSKHEV2-4h and
pHEV4TW-1h to produce infectious viral particles in vitro
suggests that the ORF2 gene, along with its adjacent JR,
ORF3 and 39NCR, is exchangeable between genotype 4
human HEV and genotype 1 human HEV. The lack of
detectable infectivity in cells inoculated with chimeras
pSKHEV2-3p and pSHEV3-1h could be explained by a
low level of virus replication in the transfected Huh7 cells
that led to reduced yields of infectious viruses. In addition, it
is possible that the viral genes from genotype 1 human HEV
may not be compatible with those from genotype 3 swine
HEV, suggesting a need for homologous gene sequences for
efficient assembly of infectious virus particles.
To determine further the infectivity of the four inter-
genotypic chimeric viruses, capped RNA transcripts from
the four chimeras were inoculated intrahepatically into
the livers of pigs. The RNA transcripts from chimeras
pSKHEV2-4h and pSKHEV2-3p failed to infect pigs, as
evidenced by a lack of faecal virus shedding, viraemia or
seroconversion, which further confirmed the previous
results in pigs inoculated with lysates of transfected cells
(Feagins et al., 2011). The ORF2 capsid protein is thought
to play an important role in HEV attachment and entry
(He et al., 2008). However, the genotype 1 human HEV did
not acquire the ability to infect pigs when its ORF2 capsid
gene was replaced with that of the genotype 4 (chimera
pSKHEV2-4h) or genotype 3 (chimera pSKHEV2-3p) HEV
that naturally infects pigs. Binding to the cells followed by
virus entry is just the first step required for virus
replication. Once inside the cell, the virus must interact
correctly with host-cell factors to reproduce its genome and
package the progeny virions (de Chassey et al., 2008;
Fernandez-Garcia et al., 2009; Panavas et al., 2005). Some
of the host factors that are key determinants for virus
replication are virus specific (Jiang et al., 2006; Quadt et al.,
1993; Strauss & Strauss, 1994). The inability of the inter-
genotypic chimeras pSKHEV2-4h and pSKHEV2-3p to
infect pigs could be explained by the lack of essential host
factors in the swine cells required by the ORF1 non-struc-
tural proteins of the genotype 1 human HEV backbone in
both chimeras. Non-structural viral genes dispensable for
virus replication are also known to play a role in modu-
lating the host immune response (Chen et al., 2010; Sun
et al., 2010), and the viral mechanisms to counteract the
host immune response can be species specific as well. The
ORF1 non-structural proteins of the genotype 1 human
HEV backbone in chimeras pSKHEV2-4h and pSKHEV2-
3p may not contain species-specific amino acid residues
important for evading the immune response in the pig, and
therefore the virus cannot establish an infection in pigs. It
has been demonstrated recently that insertion of a human
rRNA sequence in the HVR of ORF1 from a genotype 3
HEV renders the virus capable of infecting cells of multiple
species (Shukla et al., 2011), suggesting a potential role for
ORF1, particularly the HVR, in interspecies infection.
Similarly, pigs inoculated with chimeric viruses pSHEV3-
1h and pHEV4TW-1h containing the 59NCR and ORF1
from genotype 3 and genotype 4 HEV, respectively, did not
show any evidence of HEV infection, except for a single pig
inoculated with chimera pSHEV3-1h, which had detectable
HEV RNA in bile at necropsy. Capsid proteins determine
the host range of many RNA viruses (Geissler et al., 1999;
Moss & Racaniello, 1991). However, it has been demon-
strated recently that strains Sar-55 and Akluj of human
HEV can infect LLC-PK1 swine cells (Shukla et al., 2011),
suggesting that human and swine HEV strains may share at
least one cell receptor. The detection of HEV RNA in the
bile of one pig (#157) inoculated with chimera pSHEV3-1h
suggested that ORF2 protein from genotype 1 human HEV
was able to bind to a swine cell receptor, although much
less efficiently than the wild-type pSHEV-3 and pHEV-4TW
virus. The lack of viraemia or faecal virus shedding in pig
#157 may reflect an extremely low and undetectable level of
HEV in the sera and faeces. ORF3 protein is responsible for
virion egress from infected cells (Emerson et al., 2010a;
Yamada et al., 2009), probably through interactions with
cellular proteins (Korkaya et al., 2001; Surjit et al., 2006;
Zafrullah et al., 1997). ORF3 from genotype 1 human HEV
in chimeras pSHEV3-1h and pHEV4TW-1h may not inter-
act efficiently with pig cellular proteins that are potentially
involved in viral release, which may have a negative impact
on the replication of the chimeric viruses. The stem–loop
structures within the JR and 39NCR of HEV are known to
interact with the viral RdRp and possibly with host factors
required for virus replication (Agrawal et al., 2001; Cao et al.,
2010). The lack of viraemia and faecal virus shedding in the
pigs inoculated with chimera pSHEV3-1h or pHEV4TW-1h
may be a reflection of the functional importance of these
species-specific protein–protein interactions during HEV
replication.
In conclusion, we have constructed successfully, for the
first time, an infectious cDNA clone of genotype 4 human
HEV, and demonstrated that this full-length cDNA clone
of the genotype 4 human HEV is infectious in cultured
human liver cells and in pigs. Additionally, we demonstrated
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the utility of this new genotype 4 HEV infectious clone in
studying the mechanism of HEV cross-species infection.
Although the molecular mechanisms leading to interspecies
transmission of HEV remain unknown, the results from this
study suggest that species-specific interactions between viral
and cellular proteins are probably important for successful
replication of HEV in the host. Further in-depth structural
and functional studies are required to define the sequence(s)
that confer the ability of HEV to overcome the host range
barriers.
METHODS
Virus and cells. The infectious stock of the genotype 4 human HEV
strain TW6196E used in this study was prepared as a 10% suspension
of faecal material collected from an experimentally infected pig
(Feagins et al., 2008). A subclone of a human hepatoma cell line
(Huh7-S10-3) was maintained in Dulbecco’s modified Eagle’s
medium containing 10% FBS at 37 uC and 5% CO2. Human
HepG2/C3A (CRL-10741) hepatocellular carcinoma cells were
purchased from the ATCC and propagated in Eagle’s minimum
essential medium supplemented with 10% FBS at 37 uC and 5%
CO2.
Determination of the complete genomic sequence of the
genotype 4 human HEV TW6196E. Total RNA was extracted from
the TW6196E virus stock as described previously (Cooper et al., 2005;
Huang et al., 2002) and used in 39RACE, 59RACE and primer walking
to determine the complete genomic sequence of TW6196E. Briefly, a
TW6196E ORF2-specific primer based on an available 346 bp
sequence was used with 39RACE to amplify the 39 end of the viral
genome. Degenerate primers were subsequently designed based on the
sequences of the 39RACE product and other known genotype 4 strains
to amplify a 1–2 kb fragment upstream of the 39-end RACE product
using a SuperScript III One-step RT-PCR System with a Platinum
Taq High Fidelity kit (Invitrogen). PCR products of the expected sizes
were gel purified (Geneclean II kit; QBiogene), cloned into a TA
vector (Invitrogen) and sequenced. The primer-walking method was
used to amplify the majority of the genome (from the 59 to the 39
end), with the exception of the extreme 59-end sequence, which was
determined using 59 RACE.
Construction of a full-length cDNA clone of genotype 4 human
HEV TW6196E. Three overlapping genomic fragments covering the
entire viral genome were amplified by PCR using three different sets
of PCR primers (Fig. 1). Fragment I was amplified with primers
XbaIT7F and BamHI2450R (Table S1). The forward primer XbaIT7F
contained an engineered XbaI site and a T7 promoter sequence
followed by the extreme 59 end of the viral genome. Fragment II,
representing the middle portion of the viral genome, was amplified
with primers BamHI2439F and EcoRI5865R, which partially over-
lapped fragments I and III. Fragment III was amplified with primers
EcoRI5854F and ClaI7256R. The reverse primer ClaI7256R intro-
duced 18 As and SpeI and ClaI sites at the 39 end of the viral genome
for linearization and cloning purposes. Fragments I and II were
ligated simultaneously into pGEM-7zf(2) vector between the XbaI
and EcoRI sites in a three-way ligation reaction. Fragment III was
subsequently ligated into the pGEM-7zf(2) vector using the EcoRI
site partially overlapping fragment II and the ClaI site in the pGEM-
7zf(2) vector. A QuikChange Site-Directed Mutagenesis kit (Stra-
tagene) was subsequently used to delete the built-in T7 promoter
sequence in the pGEM-7zf(2) vector. Unwanted mutations in the
clone were corrected by site-directed mutagenesis to produce a final
full-length cDNA clone designated pHEV-4TW.
Construction of intergenotypic chimeric HEV cDNA clones. The
pHEV-4TW clone from this study along with HEV genotype 1 human
(pSK-HEV-2) and genotype 3 swine (pSHEV-3) HEV infectious
clones (Emerson et al., 2001; Huang et al., 2005) were used as the
backbones to construct four intergenotypic chimeric virus clones. The
ORF2 gene along with its adjacent JR, ORF3 and 39NCR were
swapped between genotypes 1 and 4, and between genotypes 1 and 3,
to produce four chimeric clones: pSKHEV2-4h, pSKHEV2-3p,
pHEV4TW-1h and pSHEV3-1h (Fig. 5). By using the genotype 4
human HEV clone pHEV-4TW as the genomic backbone, chimera
pHEV4TW-1h was generated by replacing the JR, ORF3, ORF2 and
39NCR region of genotype 4 human HEV with that of genotype 1
human HEV (Fig. 5b). To construct the chimera pSHEV3-1h, the
genotype 3 swine HEV infectious clone pSHEV-3 was used as the
genomic backbone, in which the ORF2 gene along with the JR, ORF3
and 39NCR region of the genotype 3 swine HEV was replaced with
that of the genotype 1 human HEV (Fig. 5c). Standard and fusion
PCRs with primer pairs SbfI-F/JR-R and JR-F/BglIIClaI-R (chimera
pHEV4TW-1h), and ApaI-F/JR-R and JR-F/XbaI-R (chimera
pSHEV3-1h) (Table S1) were used to produce the final fragments,
which were cloned into the corresponding region of the genotype 4 or
genotype 3 infectious clone HEV backbone. The construction of
chimeras pSKHEV2-4h and pSKHEV2-3p has been described
previously (Feagins et al., 2011) (Fig. 5a).
In vitro RNA transcription. The plasmid DNAs from each parental
and chimeric clone were linearized with AclI (pSKHEV2-4h and
pSKHEV2-3p), XbaI (pSHEV3-1h and pSHEV-3), BglII (pHEV4TW-
1h) or SpeI (pHEV-4TW). The capped RNA transcripts for the in vivo
infectivity assay were synthesized using an mMessage mMachine T7
kit (Ambion), as described previously (Co´rdoba et al., 2011), diluted
with 3 vols cold RNase/DNase/proteinase-free PBS, frozen immedi-
ately on dry ice and used for direct intrahepatic inoculation of pigs
the next day.
In vitro transfection. Full-length capped RNA transcripts from
genotype 3 pSHEV-3 and genotype 4 pHEV-4TW, and each of the
four intergenotypic chimeric clones, were transfected into Huh7 cells,
as described previously (Co´rdoba et al., 2011; Emerson et al., 2004b).
At 3 days post-transfection at 34.5 uC, the cells were trypsinized and
replated in eight-well LabTek chamber slides, and the incubation was
continued at 34.5 uC for a further 3 days. The remaining cells were
transferred to a T75 flask to produce virus stock.
Preparation of cell lysates and in vitro infectivity assays. To
generate virus stock for the in vitro infectivity assays, confluent
monolayers of Huh7 cells in T75 flasks transfected with the genotype
3 swine HEV, genotype 4 human HEV and each of the four chimeric
clones were harvested at 9 days post-transfection and centrifuged.
The pellets were resuspended in 0.9 ml water. After three freeze–thaw
cycles (280 uC), 0.1 ml 106 concentrated PBS was added and debris
was removed by centrifugation. Confluent monolayers of HepG2/C3A
cells grown in eight-well glass chamber slides were inoculated with
100 ml each cell lysate. After 5 h incubation at 34.5 uC, 0.4 ml growth
medium was added to each well and the cells were incubated for
6 days at 34.5 uC.
Immunofluorescence assay (IFA). Transfected and infected cells
were fixed and stained on day 6, as described previously (Co´rdoba
et al., 2011; Emerson et al., 2004b). Briefly, cells were fixed with
acetone, washed with PBS and incubated with chimpanzee 1313 anti-
HEV convalescent-phase serum. Cells were rinsed with PBS and over-
laid with Alexa Fluor 488-conjugated goat anti-human IgG (Molecular
Probes). The slides were washed in PBS, and Vectashield fluorescent
mounting medium (Vector Laboratories) was added for viewing by
fluorescence microscopy.
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Intrahepatic inoculation of SPF pigs with capped RNA
transcripts derived from the genotype 4 human HEV pHEV-
4TW and intergenotypic chimeric virus clones. Twenty-one 4-
week-old, HEV-seronegative SPF pigs were divided into seven groups
(A–G) of three pigs each and each group was housed separately. Pigs
were inoculated intrahepatically using an ultrasound-guided tech-
nique into four different sites of the liver, with ~200 ml capped RNA
transcripts per injection site. The three pigs in group A were each
injected with 0.8 ml of the capped RNA transcripts from the
genotype 3 HEV pSHEV-3 clone (positive control). Group B pigs
were each injected similarly with 0.8 ml capped RNA transcripts
from the genotype 4 human HEV pHEV-4TW clone. Pigs in groups
C–F were each injected with 0.8 ml capped RNA transcripts from the
HEV chimeric clones pSKHEV2-4h, pSKHEV2-3p, pHEV4TW-1h
and pSHEV3-1h, respectively. Pigs in group G were injected with
PBS (negative control). The animals were monitored for evidence of
HEV infection for a total of 8 weeks, at which time they were
necropsied. Serum samples and faecal swab material were collected
prior to inoculation and weekly thereafter. At necropsy, samples of
serum, bile, liver and intestinal contents were collected from each
pig.
Serology. Serum samples were tested for anti-HEV IgG using an
ELISA, essentially as described previously (Co´rdoba et al., 2011). Pre-
immune and hyperimmune IgG anti-HEV swine sera were included as
negative and positive controls, respectively. The ELISA cut-off value
was calculated as the mean negative-control absorbance value plus 3 SD.
RNA extraction and RT-PCR. Viraemia, faecal virus shedding and
the presence of HEV RNA in bile, liver and intestinal content were
tested by a nested RT-PCR using primers targeting the ORF2 gene
(Table S1), as described previously (Co´rdoba et al., 2011). For
detection of wild-type genotype 3 HEV pSHEV-3 and the chimeric
pSKHEV2-3p, nested RT-PCR primer pairs 3pEX-F/3pEX-R (first
round) and 3pIN-F/3pIN-R (second round) were used (Table S1).
Primer pairs 4hEX-F/4hEX-R (first round) and 4hIN-F/4hIN-R
(second round) were used for detection of wild-type genotype 4
HEV pHEV-4TW and chimeric pSKHEV2-4h. Primer pairs 1hEX-F/
1hEX-R (first round) and 1hIN-F/1hIN-R (second round) were used
to detect chimeras pHEV4TW-1h and pSHEV3-1h.
To confirm the positive PCR results, two additional sets of nested RT-
PCR primers targeting a different genomic region were designed
(a) Genotype 1 human HEV as the genomic backbone
JR
NCRNCR
(5′) T7p A12 (3′)ORF2
ORF3
ORF1
Chimera pSKHEV2-4h
Chimera pSKHEV2-3p
Chimera pHEV4TW-1h
Chimera pSHEV3-1h
Genotype 4 human HEV
JR
NCRNCR
(5′) T7p A12 (3′)ORF2
ORF3
ORF1
Genotype 3 swine HEV
(b) Genotype 4 human HEV as the genomic backbone
JR
NCRNCR
(5′) T7p A18 (3′)ORF2
ORF3
ORF1
Genotype 1 human HEV
(c) Genotype 3 swine HEV as the genomic backbone
JR
NCRNCR
(5′) T7p A15(3′)ORF2
ORF3
ORF1
Genotype 1 human HEV
Fig. 5. Schematic diagrams of the strategies used for construction of the four intergenotypic chimeric HEVs. (a) Two chimeric
viruses were constructed using the genotype 1 human HEV infectious clone pSK-HEV-2 as the genomic backbone: chimera
pSKHEV2-4h with the JR+ORF2+ORF3+39NCR of genotype 4 human HEV replacing that of genotype 1 human HEV; and
chimera pSKHEV2-3p with the JR+ORF2+ORF3+39NCR of genotype 3 swine HEV replacing that of genotype 1 human
HEV. (b) Chimera pHEV4TW-1h was constructed using the genotype 4 human HEV infectious clone pHEVTW-4 as the
genomic backbone, with the JR+ORF2+ORF3+39NCR of genotype 1 human HEV replacing that of genotype 4 human HEV.
(c) Chimera pSHEV3-1h was constructed by using the genotype 3 swine HEV infectious clone pSHEV-3 as the genomic
backbone, with the JR+ORF2+ORF3+39NCR of genotype 1 human HEV replacing that of genotype 3 swine HEV.
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within the ORF1 gene of genotype 3 swine and genotype 4 human
HEV (Table S1). The PCR products were sequenced to confirm that
the viruses recovered from pigs originated from their respective
inoculum.
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